Skip to main content
Erschienen in: Annals of Hematology 9/2020

15.07.2020 | Review Article

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies

verfasst von: Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino

Erschienen in: Annals of Hematology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

In October 2019, a viral infectious disease appeared in the city of Wuhan in China. A new betacoronavirus, SARS-CoV-2, has been recognized as the responsible pathogen in this infection. Although coronavirus disease is principally expressed as a pulmonary infection, critical SARS-CoV-2 infection is frequently complicated with coagulopathy, and thromboembolic events are recognizable in several patients. Dehydration, acute inflammatory condition, protracted immobilization during disease, existence of multiple cardiovascular risk factors such as diabetes, obesity or hypertension, previous coronary artery disease, ischemic stroke, peripheral artery disease are frequent comorbidities in SARS-CoV-2 hospitalized subjects, which possibly augment thrombo-embolic risk. However, other causal factors can still be identified such as unrestricted angiotensin II action, the use of immunoglobulins, an increased production of adhesion molecules able to induce vascular inflammation and endothelial activation, complement stimulation, excessive production of neutrophil extracellular traps (NETs), and increased platelet count. Low-molecular-weight heparin should be chosen as early treatment because of its anti-inflammatory action and its ability to antagonize histones and so defend the endothelium. However, several therapeutic possibilities have also been proposed such as fibrinolytic treatment, drugs that target NETs, and complement inhibition. Nevertheless, although the violence of the pandemic may suggest the use of heroic treatments to reduce the frightening mortality that accompanies SARS-CoV-2 infection, we believe that experimental treatments should only be used within approved and controlled protocols, the only ones that can provide useful and specify information on the validity of the treatments.
Literatur
1.
Zurück zum Zitat Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382(13):1199–1207PubMedPubMedCentral Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382(13):1199–1207PubMedPubMedCentral
2.
Zurück zum Zitat Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, Xing F, Liu J, Yip CC-Y, Poon RW-S, Tsoi H-W, Lo SK-F, Chan K-H, Poon VK-M, Chan W-M, Ip JD, Cai J-P, Cheng VC-C, Chen H, Hui CK-M, Yuen K-Y (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 395(10223):514–523PubMedPubMedCentral Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, Xing F, Liu J, Yip CC-Y, Poon RW-S, Tsoi H-W, Lo SK-F, Chan K-H, Poon VK-M, Chan W-M, Ip JD, Cai J-P, Cheng VC-C, Chen H, Hui CK-M, Yuen K-Y (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 395(10223):514–523PubMedPubMedCentral
3.
Zurück zum Zitat Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, Brown TS, Nigoghossian CD, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ (2020) Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol 18 S0735-1097(20)34637-4 Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, Brown TS, Nigoghossian CD, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ (2020) Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol 18 S0735-1097(20)34637-4
5.
Zurück zum Zitat Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034PubMedPubMedCentral Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034PubMedPubMedCentral
6.
Zurück zum Zitat Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. 2019PubMedPubMedCentral Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. 2019PubMedPubMedCentral
7.
Zurück zum Zitat Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395(10223):497–506PubMedPubMedCentral Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395(10223):497–506PubMedPubMedCentral
8.
Zurück zum Zitat Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma WG (2012) D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med 23(5):436–441PubMed Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma WG (2012) D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med 23(5):436–441PubMed
9.
Zurück zum Zitat Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA:e201585. https://doi.org/10.1001/jama.2020.1585 Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA:e201585. https://​doi.​org/​10.​1001/​jama.​2020.​1585
10.
Zurück zum Zitat Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062PubMedPubMedCentral Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062PubMedPubMedCentral
11.
Zurück zum Zitat Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847PubMedPubMedCentral Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844–847PubMedPubMedCentral
13.
Zurück zum Zitat Kitchens CS (2009) Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Hematology/the Education Program of the American Society of Hematology 240–246. Kitchens CS (2009) Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Hematology/the Education Program of the American Society of Hematology 240–246.
14.
Zurück zum Zitat Gralinski LE, Bankhead A 3rd, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS (2013) Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio 4(4) Gralinski LE, Bankhead A 3rd, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS (2013) Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio 4(4)
15.
Zurück zum Zitat Berri F, Rimmelzwaan GF, Hanss M, Albina E, Foucault-Grunenwald ML, Lê VB, Vogelzang-van Trierum SE, Gil P, Camerer E, Martinez D, Lina B, Lijnen R, Carmeliet P, Riteau B (2013) Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog 9(3):e1003229PubMedPubMedCentral Berri F, Rimmelzwaan GF, Hanss M, Albina E, Foucault-Grunenwald ML, Lê VB, Vogelzang-van Trierum SE, Gil P, Camerer E, Martinez D, Lina B, Lijnen R, Carmeliet P, Riteau B (2013) Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. PLoS Pathog 9(3):e1003229PubMedPubMedCentral
16.
Zurück zum Zitat Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A (2020) Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. https://doi.org/10.1111/jth.14850 Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A (2020) Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. https://​doi.​org/​10.​1111/​jth.​14850
17.
Zurück zum Zitat Zhang C, Shi L, Wang F (2020) Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 5(5):428–430PubMedPubMedCentral Zhang C, Shi L, Wang F (2020) Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 5(5):428–430PubMedPubMedCentral
20.
Zurück zum Zitat Helms J, Tacquard C, Severac F et al (2020) CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med:1–10. https://doi.org/10.1007/s00134-020-06062-x Helms J, Tacquard C, Severac F et al (2020) CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med:1–10. https://​doi.​org/​10.​1007/​s00134-020-06062-x
21.
Zurück zum Zitat Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60PubMed Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60PubMed
25.
Zurück zum Zitat Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D, Fowler R, Pai M, Guyatt G, Crowther MA, Warkentin TE, Devereaux PJ, Walter SD, Muscedere J, Herridge M, Turgeon AF, Geerts W, Finfer S, Jacka M, Berwanger O, Ostermann M, Qushmaq I, Friedrich JO, Cook DJ, PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators (2015) Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients multicenter study; randomized controlled trial. Crit Care Med 43(2):401–410PubMed Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D, Fowler R, Pai M, Guyatt G, Crowther MA, Warkentin TE, Devereaux PJ, Walter SD, Muscedere J, Herridge M, Turgeon AF, Geerts W, Finfer S, Jacka M, Berwanger O, Ostermann M, Qushmaq I, Friedrich JO, Cook DJ, PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators (2015) Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients multicenter study; randomized controlled trial. Crit Care Med 43(2):401–410PubMed
27.
Zurück zum Zitat Zakai NA, McClure LA (2011) Racial differences in venous thromboembolism. J Thromb Haemost 9:1877–1882PubMed Zakai NA, McClure LA (2011) Racial differences in venous thromboembolism. J Thromb Haemost 9:1877–1882PubMed
28.
Zurück zum Zitat Boisrame-Helms J, Kremer H, Schini-Kerth V, Meziani F (2013) Endothelial dysfunction in sepsis. Curr Vasc Pharmacol 11:150–160PubMed Boisrame-Helms J, Kremer H, Schini-Kerth V, Meziani F (2013) Endothelial dysfunction in sepsis. Curr Vasc Pharmacol 11:150–160PubMed
29.
Zurück zum Zitat Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT (2009) Extracellular histones are major mediators of death in sepsis. Nat Med 15(11):1318–1321PubMedPubMedCentral Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT (2009) Extracellular histones are major mediators of death in sepsis. Nat Med 15(11):1318–1321PubMedPubMedCentral
30.
Zurück zum Zitat Boccia M, Aronne L, Celia B, Mazzeo G, Ceparano M, D’Agnano V, Parrella R, Valente Y, Bianco A, Perrotta F (2020) COVID-19 and coagulative axis: review of emerging aspects in a novel disease. Monaldi Arch Chest Dis 90(2). https://doi.org/10.4081/monaldi.2020.1300 Published 2020 May 19 Boccia M, Aronne L, Celia B, Mazzeo G, Ceparano M, D’Agnano V, Parrella R, Valente Y, Bianco A, Perrotta F (2020) COVID-19 and coagulative axis: review of emerging aspects in a novel disease. Monaldi Arch Chest Dis 90(2). https://​doi.​org/​10.​4081/​monaldi.​2020.​1300 Published 2020 May 19
31.
Zurück zum Zitat Bucciarelli P, Martinelli I, Artoni A, Passamonti SM, Previtali E, Merati G, Tripodi A, Mannucci PM (2012) Circulating microparticles and risk of venous thromboembolism. Thromb Res 129:591–597PubMed Bucciarelli P, Martinelli I, Artoni A, Passamonti SM, Previtali E, Merati G, Tripodi A, Mannucci PM (2012) Circulating microparticles and risk of venous thromboembolism. Thromb Res 129:591–597PubMed
32.
Zurück zum Zitat Raeven P, Zipperle J, Drechsler S (2018) Extracellular vesicles as markers and mediators in sepsis. Theranostics 8:3348–3365PubMedPubMedCentral Raeven P, Zipperle J, Drechsler S (2018) Extracellular vesicles as markers and mediators in sepsis. Theranostics 8:3348–3365PubMedPubMedCentral
33.
Zurück zum Zitat Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, Nácher M, Pitaval C, Radovanovic I, Fukui Y, McEver RP, Filippi MD, Lizasoain I, Ruiz-Cabello J, Zarbock A, Moro MA, Hidalgo A (2014) Neutrophils scan for activated platelets to initiate inflammation. Science. 346:1234–1238PubMedPubMedCentral Sreeramkumar V, Adrover JM, Ballesteros I, Cuartero MI, Rossaint J, Bilbao I, Nácher M, Pitaval C, Radovanovic I, Fukui Y, McEver RP, Filippi MD, Lizasoain I, Ruiz-Cabello J, Zarbock A, Moro MA, Hidalgo A (2014) Neutrophils scan for activated platelets to initiate inflammation. Science. 346:1234–1238PubMedPubMedCentral
35.
Zurück zum Zitat Tagami T, Tosa R, Omura M, Fukushima H, Kaneko T, Endo T, Rinka H, Murai A, Yamaguchi J, Yoshikawa K, Saito N, Uzu H, Kase Y, Takatori M, Izumino H, Nakamura T, Seo R, Kitazawa Y, Sugita M, Takahashi H, Kuroki Y, Irahara T, Kanemura T, Yokota H, Kushimoto S (2014) Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study. J Intensive Care 2:67PubMedPubMedCentral Tagami T, Tosa R, Omura M, Fukushima H, Kaneko T, Endo T, Rinka H, Murai A, Yamaguchi J, Yoshikawa K, Saito N, Uzu H, Kase Y, Takatori M, Izumino H, Nakamura T, Seo R, Kitazawa Y, Sugita M, Takahashi H, Kuroki Y, Irahara T, Kanemura T, Yokota H, Kushimoto S (2014) Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study. J Intensive Care 2:67PubMedPubMedCentral
36.
Zurück zum Zitat Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science. 303:1532–1535PubMed Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science. 303:1532–1535PubMed
37.
Zurück zum Zitat Sollberger G, Choidas A, Burn GL, Habenberger P, Di Lucrezia R, Kordes S, Menninge S, Eickhoff J, Nussbaumer P, Klebl B, Krüger R, Herzig A, Zychlinsky A (2018) Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol 3:eaar6689PubMed Sollberger G, Choidas A, Burn GL, Habenberger P, Di Lucrezia R, Kordes S, Menninge S, Eickhoff J, Nussbaumer P, Klebl B, Krüger R, Herzig A, Zychlinsky A (2018) Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol 3:eaar6689PubMed
39.
Zurück zum Zitat Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18:134–147PubMed Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18:134–147PubMed
41.
Zurück zum Zitat Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107:15880–15,885PubMedPubMedCentral Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107:15880–15,885PubMedPubMedCentral
42.
Zurück zum Zitat Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT (2011) Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J. Thromb Haemost 9:1795–1803 Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT (2011) Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J. Thromb Haemost 9:1795–1803
43.
Zurück zum Zitat Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Cate HT, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BLJH (2013) Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 33:2032–2040PubMedPubMedCentral Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Cate HT, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BLJH (2013) Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 33:2032–2040PubMedPubMedCentral
44.
Zurück zum Zitat Laridan E, Martinod K, De Meyer SF (2019) Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 45:86–93PubMed Laridan E, Martinod K, De Meyer SF (2019) Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 45:86–93PubMed
45.
Zurück zum Zitat Jiménez-Alcázar M, Rangaswamy C, Panda R, Bitterling J, Yashin J, Long AT, Bilyy R, Krenn V, Renné C, Renné T, Kluge S, Panzer U, Mizuta R, Mannherz HG, Kitamura D, Herrmann M, Napirei M, Fuchs TA (2017) Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. 358:1202–1206PubMed Jiménez-Alcázar M, Rangaswamy C, Panda R, Bitterling J, Yashin J, Long AT, Bilyy R, Krenn V, Renné C, Renné T, Kluge S, Panzer U, Mizuta R, Mannherz HG, Kitamura D, Herrmann M, Napirei M, Fuchs TA (2017) Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. 358:1202–1206PubMed
46.
Zurück zum Zitat Oehmcke S, Morgelin M, Herwald H (2009) Activation of the human contact system on neutrophil extracellular traps. J Innate Immun 1:225–230PubMedPubMedCentral Oehmcke S, Morgelin M, Herwald H (2009) Activation of the human contact system on neutrophil extracellular traps. J Innate Immun 1:225–230PubMedPubMedCentral
47.
Zurück zum Zitat Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, Esmon CT (2011) Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 118:1952–1961PubMedPubMedCentral Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, Esmon CT (2011) Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 118:1952–1961PubMedPubMedCentral
48.
Zurück zum Zitat Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, Konrad I, Kennerknecht E, Reges K, Holdenrieder S, Braun S, Reinhardt C, Spannagl M, Preissner KT, Engelmann B (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887–896PubMed Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, Konrad I, Kennerknecht E, Reges K, Holdenrieder S, Braun S, Reinhardt C, Spannagl M, Preissner KT, Engelmann B (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 16:887–896PubMed
49.
Zurück zum Zitat Raup-Konsavage WM, Wang Y, Wang WW, Feliers D, Ruan H, Reeves WB (2018) Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int 93:365–374PubMed Raup-Konsavage WM, Wang Y, Wang WW, Feliers D, Ruan H, Reeves WB (2018) Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int 93:365–374PubMed
51.
Zurück zum Zitat Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145–148PubMedPubMedCentral Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145–148PubMedPubMedCentral
52.
54.
Zurück zum Zitat Menter DG, Kopetz S, Hawk E, Sood AK, Loree JM, Gresele P, Honn KV (2017) Platelet “first responders” in wound response, cancer, and metastasis. Cancer Metastasis Rev 36(2):199–213PubMedPubMedCentral Menter DG, Kopetz S, Hawk E, Sood AK, Loree JM, Gresele P, Honn KV (2017) Platelet “first responders” in wound response, cancer, and metastasis. Cancer Metastasis Rev 36(2):199–213PubMedPubMedCentral
55.
Zurück zum Zitat Witkowski M, Landmesser U, Rauch U (2016) Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med 26:297–303PubMed Witkowski M, Landmesser U, Rauch U (2016) Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med 26:297–303PubMed
56.
Zurück zum Zitat Levi M, van der Poll T (2017) Coagulation and sepsis. Thromb Res 149:38–44PubMed Levi M, van der Poll T (2017) Coagulation and sepsis. Thromb Res 149:38–44PubMed
57.
Zurück zum Zitat Schmitt FCF, Manolov V, Morgenstern J, Fleming T, Heitmeier S, Uhle F, Al-Saeedi M, Hackert T, Bruckner T, Schöchl H, Weigand MA, Hofer S, Brenner T (2019) Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9(1):19PubMedPubMedCentral Schmitt FCF, Manolov V, Morgenstern J, Fleming T, Heitmeier S, Uhle F, Al-Saeedi M, Hackert T, Bruckner T, Schöchl H, Weigand MA, Hofer S, Brenner T (2019) Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9(1):19PubMedPubMedCentral
59.
Zurück zum Zitat Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA (2020) Hematological findings and complications of COVID-19. Am J Hematol. https://doi.org/10.1002/ajh.25829 Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA (2020) Hematological findings and complications of COVID-19. Am J Hematol. https://​doi.​org/​10.​1002/​ajh.​25829
60.
Zurück zum Zitat Isidori AM, Minnetti M, Sbardella E, Graziadio C, Grossman AB (2015) Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol 173(3):R101–R113PubMed Isidori AM, Minnetti M, Sbardella E, Graziadio C, Grossman AB (2015) Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol 173(3):R101–R113PubMed
61.
Zurück zum Zitat Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63:364–374PubMedPubMedCentral Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63:364–374PubMedPubMedCentral
63.
Zurück zum Zitat Lin CI, Tsai CH, Sun YL, Hsieh WY, Lin YC, Chen CY, Lin CS (2018) Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE-2 knockout mice. Int J Biol Sci 14:253–265PubMedPubMedCentral Lin CI, Tsai CH, Sun YL, Hsieh WY, Lin YC, Chen CY, Lin CS (2018) Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE-2 knockout mice. Int J Biol Sci 14:253–265PubMedPubMedCentral
64.
Zurück zum Zitat Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Nigoghossian CD, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré B, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYHGlobal COVID-19 Thrombosis Collaborative Group (2020) Pharmacological agents targeting thrombo-inflammation in COVID-19: review and implications for future research. Thromb Haemost. https://doi.org/10.1055/s-0040-1,713,152 Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Nigoghossian CD, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré B, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYHGlobal COVID-19 Thrombosis Collaborative Group (2020) Pharmacological agents targeting thrombo-inflammation in COVID-19: review and implications for future research. Thromb Haemost. https://​doi.​org/​10.​1055/​s-0040-1,713,152
65.
Zurück zum Zitat Gupta N, Zhao YY, Evans CE (2019) The stimulation of thrombosis by hypoxia. Thromb Res 181:77–83PubMed Gupta N, Zhao YY, Evans CE (2019) The stimulation of thrombosis by hypoxia. Thromb Res 181:77–83PubMed
68.
Zurück zum Zitat Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir Res 176:104742PubMed Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir Res 176:104742PubMed
71.
Zurück zum Zitat Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S (2020) SARS-CoV-2 cell entry depends on ACE-2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https://doi.org/10.1016/j.cell.2020.02.052 Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S (2020) SARS-CoV-2 cell entry depends on ACE-2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https://​doi.​org/​10.​1016/​j.​cell.​2020.​02.​052
72.
Zurück zum Zitat Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454PubMedPubMedCentral Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454PubMedPubMedCentral
73.
Zurück zum Zitat Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J (2009) SARS coronavirus modulation of myocardial ACE-2 expression and inflammation in patients with SARS. Eur J Clin Investig 39:618–625 Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J (2009) SARS coronavirus modulation of myocardial ACE-2 expression and inflammation in patients with SARS. Eur J Clin Investig 39:618–625
74.
Zurück zum Zitat Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY (2020) A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect 9(1):558–570PubMed Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY (2020) A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect 9(1):558–570PubMed
75.
Zurück zum Zitat Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS (2006) Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia—a review. Crit Care Med 34(3):871–877PubMed Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS (2006) Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia—a review. Crit Care Med 34(3):871–877PubMed
76.
Zurück zum Zitat Kerr R, Stirling D, Ludlam CA (2001) Interleukin 6 and haemostasis. Br J Haematol 115:3–12PubMed Kerr R, Stirling D, Ludlam CA (2001) Interleukin 6 and haemostasis. Br J Haematol 115:3–12PubMed
77.
Zurück zum Zitat Bode M, Mackman N (2014) Regulation of tissue factor gene expression in monocytes and endothelial cells: thromboxane A2 as a new player. Vasc Pharmacol 62:57–62 Bode M, Mackman N (2014) Regulation of tissue factor gene expression in monocytes and endothelial cells: thromboxane A2 as a new player. Vasc Pharmacol 62:57–62
78.
Zurück zum Zitat Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, Ferraz da Silva LF, de Oliveira EP, Saldiva PHN, Mauad T, Negri EM (2020) Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. https://doi.org/10.1111/jth.14844 Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, Ferraz da Silva LF, de Oliveira EP, Saldiva PHN, Mauad T, Negri EM (2020) Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. https://​doi.​org/​10.​1111/​jth.​14844
80.
Zurück zum Zitat Prufer F, Scheiring J, Sautter S, Jensen DB, Treichl R, Würzner R, Zimmerhackl LB (2006) Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome. Semin Thromb Hemost 32:121–127PubMed Prufer F, Scheiring J, Sautter S, Jensen DB, Treichl R, Würzner R, Zimmerhackl LB (2006) Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome. Semin Thromb Hemost 32:121–127PubMed
81.
Zurück zum Zitat Chaturvedi S, Braunstein EM, Yuan X, Yu J, Alexander A, Chen H, Gavriilaki E, Alluri R, Streiff MB, Petri M, Crowther MA, McCrae KR, Brodsky RA (2020) Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood 135:239–251PubMedPubMedCentral Chaturvedi S, Braunstein EM, Yuan X, Yu J, Alexander A, Chen H, Gavriilaki E, Alluri R, Streiff MB, Petri M, Crowther MA, McCrae KR, Brodsky RA (2020) Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood 135:239–251PubMedPubMedCentral
82.
Zurück zum Zitat Zhou Y, Lu K, Pfefferle S, Bertram S, Glowacka I, Drosten C, Pöhlmann S, Simmons G (2010) A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms. J Virol 84:8753–8764PubMedPubMedCentral Zhou Y, Lu K, Pfefferle S, Bertram S, Glowacka I, Drosten C, Pöhlmann S, Simmons G (2010) A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms. J Virol 84:8753–8764PubMedPubMedCentral
83.
Zurück zum Zitat Beltrame MH, Catarino SJ, Goeldner I, Boldt ABW, de Messias-Reason IJ (2015) The lectin pathway of complement and rheumatic heart disease. Front Pediatr 2(148):1–14 Beltrame MH, Catarino SJ, Goeldner I, Boldt ABW, de Messias-Reason IJ (2015) The lectin pathway of complement and rheumatic heart disease. Front Pediatr 2(148):1–14
84.
Zurück zum Zitat Krarup A, Wallis R, Presanis JS, Gal P, Sim RB (2007) Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One 7:e623 Krarup A, Wallis R, Presanis JS, Gal P, Sim RB (2007) Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One 7:e623
86.
87.
Zurück zum Zitat Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R, Sun S, Zhou Y (2018) Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg Microbes Infect 7:77PubMedPubMedCentral Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R, Sun S, Zhou Y (2018) Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg Microbes Infect 7:77PubMedPubMedCentral
88.
Zurück zum Zitat Rits K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177:47944802 Rits K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177:47944802
89.
Zurück zum Zitat Yen Y-T, Liao F, Hsiao C-H, Kao C-L, Chen Y-C, Wu-Hsieh BA (2006) Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol 80:26842693 Yen Y-T, Liao F, Hsiao C-H, Kao C-L, Chen Y-C, Wu-Hsieh BA (2006) Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol 80:26842693
91.
Zurück zum Zitat Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O’Mahony S, Mikacenic C (2020) Covid-19 in critically ill patients in the Seattle region--case series. N Engl J Med. https://doi.org/10.1056/NEJMoa2004500 Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O’Mahony S, Mikacenic C (2020) Covid-19 in critically ill patients in the Seattle region--case series. N Engl J Med. https://​doi.​org/​10.​1056/​NEJMoa2004500
96.
Zurück zum Zitat Poterucha TJ, Libby P, Goldhaber SZ (2017) More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost 117(3):437–444PubMed Poterucha TJ, Libby P, Goldhaber SZ (2017) More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost 117(3):437–444PubMed
97.
Zurück zum Zitat Young E (2018) The anti-inflammatory effects of heparin and related compounds. Thromb Res 122(6):743–752 Young E (2018) The anti-inflammatory effects of heparin and related compounds. Thromb Res 122(6):743–752
98.
Zurück zum Zitat Li JP, Vlodavsky I (2009) Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb Haemost 102(5):823–828PubMed Li JP, Vlodavsky I (2009) Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb Haemost 102(5):823–828PubMed
99.
Zurück zum Zitat Esmon CT (2014) Targeting factor Xa and thrombin: impact on coagulation and beyond. Thromb Haemost 111(4):625–633PubMed Esmon CT (2014) Targeting factor Xa and thrombin: impact on coagulation and beyond. Thromb Haemost 111(4):625–633PubMed
100.
Zurück zum Zitat Mousavi S, Moradi M, Khorshidahmad T, Motamedi M (2015) Anti-inflammatory effects of heparin and its derivatives: a systematic review. Adv Pharmacol Sci 2015:507151PubMedPubMedCentral Mousavi S, Moradi M, Khorshidahmad T, Motamedi M (2015) Anti-inflammatory effects of heparin and its derivatives: a systematic review. Adv Pharmacol Sci 2015:507151PubMedPubMedCentral
101.
Zurück zum Zitat Iba T, Hashiguchi N, Nagaoka I, Tabe Y, Kadota K, Sato K (2015) Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction. Intensive Care Med Exp 3(1):36PubMedPubMedCentral Iba T, Hashiguchi N, Nagaoka I, Tabe Y, Kadota K, Sato K (2015) Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction. Intensive Care Med Exp 3(1):36PubMedPubMedCentral
102.
Zurück zum Zitat Zhu C, Liang Y, Li X, Chen N, Ma X (2019) Unfractionated heparin attenuates histone-mediated cytotoxicity in vitro and prevents intestinal microcirculatory dysfunction in histone-infused rats. J Trauma Acute Care Surg 87(3):614–622PubMed Zhu C, Liang Y, Li X, Chen N, Ma X (2019) Unfractionated heparin attenuates histone-mediated cytotoxicity in vitro and prevents intestinal microcirculatory dysfunction in histone-infused rats. J Trauma Acute Care Surg 87(3):614–622PubMed
103.
Zurück zum Zitat Liu Y, Mu S, Li X, Liang Y, Wang L, Ma X (2019) Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions. J Surg Res 238:175–185PubMed Liu Y, Mu S, Li X, Liang Y, Wang L, Ma X (2019) Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions. J Surg Res 238:175–185PubMed
104.
Zurück zum Zitat Ma J, Bai J (2015) Protective effects of heparin on endothelial cells in sepsis. Int J Clin Exp Med 8(4):5547–5552PubMedPubMedCentral Ma J, Bai J (2015) Protective effects of heparin on endothelial cells in sepsis. Int J Clin Exp Med 8(4):5547–5552PubMedPubMedCentral
105.
Zurück zum Zitat Sun H, Wang X, Degen JL, Ginsburg D (2009) Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood. 113(6):1358–1364PubMedPubMedCentral Sun H, Wang X, Degen JL, Ginsburg D (2009) Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood. 113(6):1358–1364PubMedPubMedCentral
106.
Zurück zum Zitat Hardaway RM, Williams CH, Marvasti M, Farias M, Tseng A, Pinon I, Yanez D, Martinez M, Navar J (1990) Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Crit Care Med 18:1413–1418PubMed Hardaway RM, Williams CH, Marvasti M, Farias M, Tseng A, Pinon I, Yanez D, Martinez M, Navar J (1990) Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Crit Care Med 18:1413–1418PubMed
107.
Zurück zum Zitat Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W (2002) Management strategies and prognosis of pulmonary embolism-3 trial investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150PubMed Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W (2002) Management strategies and prognosis of pulmonary embolism-3 trial investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150PubMed
108.
Zurück zum Zitat Yost CC, Schwertz H, Cody MJ, Wallace JA, Campbell RA, Vieira-deAbreu A, Araujo CV, Schubert S, Harris ES, Rowley JW, Rondina MT, Fulcher JM, Koening CL, Weyrich AS, Zimmerman GA (2016) Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation. J Clin Invest 126:3783–3379PubMedPubMedCentral Yost CC, Schwertz H, Cody MJ, Wallace JA, Campbell RA, Vieira-deAbreu A, Araujo CV, Schubert S, Harris ES, Rowley JW, Rondina MT, Fulcher JM, Koening CL, Weyrich AS, Zimmerman GA (2016) Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation. J Clin Invest 126:3783–3379PubMedPubMedCentral
109.
Zurück zum Zitat Fuchs TA, Jimenez-Alcazar M, Gobel J, Englert H (2019) Neutrolis, Inc. US patent application US 2020/0024585 A1, filed August 20 Fuchs TA, Jimenez-Alcazar M, Gobel J, Englert H (2019) Neutrolis, Inc. US patent application US 2020/0024585 A1, filed August 20
110.
Zurück zum Zitat Lefrançais E, Mallavia B, Zhuo H, Calfee CS, Looney MR (2018) Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI Insight 3:e98178PubMedCentral Lefrançais E, Mallavia B, Zhuo H, Calfee CS, Looney MR (2018) Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI Insight 3:e98178PubMedCentral
111.
Zurück zum Zitat Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M (2020) Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 217(6):e20200652. https://doi.org/10.1084/jem.20200652CrossRefPubMedPubMedCentral Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M (2020) Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 217(6):e20200652. https://​doi.​org/​10.​1084/​jem.​20200652CrossRefPubMedPubMedCentral
112.
Zurück zum Zitat Döring Y, Libby P, Soehnlein O (2020) Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights. Circ Res 126(9):1228–1241PubMedPubMedCentral Döring Y, Libby P, Soehnlein O (2020) Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights. Circ Res 126(9):1228–1241PubMedPubMedCentral
115.
Zurück zum Zitat Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, Falco M, Albano G, Menicanti L (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. https://doi.org/10.1111/jth.14854 Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, Falco M, Albano G, Menicanti L (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. https://​doi.​org/​10.​1111/​jth.​14854
116.
Zurück zum Zitat Stein PD, Kayali F, Olson RE, Milford CE (2004) Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 116(7):435–442PubMed Stein PD, Kayali F, Olson RE, Milford CE (2004) Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 116(7):435–442PubMed
117.
Zurück zum Zitat Eikelboom JW, Hirsh J (2006) Monitoring unfractionated heparin with the aPTT: time for a fresh look. Thromb Haemost 96(05):547–552PubMed Eikelboom JW, Hirsh J (2006) Monitoring unfractionated heparin with the aPTT: time for a fresh look. Thromb Haemost 96(05):547–552PubMed
118.
Zurück zum Zitat Vandiver JW, Vondracek TG (2012) Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 32(06):546–558PubMed Vandiver JW, Vondracek TG (2012) Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 32(06):546–558PubMed
119.
Zurück zum Zitat Aikawa N, Shimazaki S, Yamamoto Y, Saito H, Maruyama I, Ohno R, Hirayama A, Aoki Y, Aoki N (2011) Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial. Shock 35(4):349–354PubMed Aikawa N, Shimazaki S, Yamamoto Y, Saito H, Maruyama I, Ohno R, Hirayama A, Aoki Y, Aoki N (2011) Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial. Shock 35(4):349–354PubMed
120.
Zurück zum Zitat Liu XL, Wang XZ, Liu XX, Hao D, Jaladat Y, Lu F, Sun T, Lv CJ (2014) Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study. Exp Ter Med 7(3):604–608 Liu XL, Wang XZ, Liu XX, Hao D, Jaladat Y, Lu F, Sun T, Lv CJ (2014) Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study. Exp Ter Med 7(3):604–608
121.
Zurück zum Zitat Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, Imaizumi H, Inoue S, Kakihana Y, Kotani J, Kushimoto S, Masuda Y, Matsuda N, Matsushima A, Nakada TA, Nakagawa S, Nunomiya S, Sadahiro T, Shime N, Yatabe T, Hara Y, Hayashida K, Kondo Y, Sumi Y, Yasuda H, Aoyama K, Azuhata T, Doi K, Doi M, Fujimura N, Fuke R, Fukuda T, Goto K, Hasegawa R, Hashimoto S, Hatakeyama J, Hayakawa M, Hifumi T, Higashibeppu N, Hirai K, Hirose T, Ide K, Kaizuka Y, Kan’o T, Kawasaki T, Kuroda H, Matsuda A, Matsumoto S, Nagae M, Onodera M, Ohnuma T, Oshima K, Saito N, Sakamoto S, Sakuraya M, Sasano M, Sato N, Sawamura A, Shimizu K, Shirai K, Takei T, Takeuchi M, Takimoto K, Taniguchi T, Tatsumi H, Tsuruta R, Yama N, Yamakawa K, Yamashita C, Yamashita K, Yoshida T, Tanaka H, Oda S (2018) The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acure Med Surg 5(1):3–89 Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, Imaizumi H, Inoue S, Kakihana Y, Kotani J, Kushimoto S, Masuda Y, Matsuda N, Matsushima A, Nakada TA, Nakagawa S, Nunomiya S, Sadahiro T, Shime N, Yatabe T, Hara Y, Hayashida K, Kondo Y, Sumi Y, Yasuda H, Aoyama K, Azuhata T, Doi K, Doi M, Fujimura N, Fuke R, Fukuda T, Goto K, Hasegawa R, Hashimoto S, Hatakeyama J, Hayakawa M, Hifumi T, Higashibeppu N, Hirai K, Hirose T, Ide K, Kaizuka Y, Kan’o T, Kawasaki T, Kuroda H, Matsuda A, Matsumoto S, Nagae M, Onodera M, Ohnuma T, Oshima K, Saito N, Sakamoto S, Sakuraya M, Sasano M, Sato N, Sawamura A, Shimizu K, Shirai K, Takei T, Takeuchi M, Takimoto K, Taniguchi T, Tatsumi H, Tsuruta R, Yama N, Yamakawa K, Yamashita C, Yamashita K, Yoshida T, Tanaka H, Oda S (2018) The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acure Med Surg 5(1):3–89
122.
Zurück zum Zitat Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S (2016) Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 14(3):518–530PubMed Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S (2016) Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 14(3):518–530PubMed
123.
Zurück zum Zitat Iba T, Gando S, Thachil J (2014) Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost 12(7):1010–1019PubMed Iba T, Gando S, Thachil J (2014) Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost 12(7):1010–1019PubMed
125.
Zurück zum Zitat Arachchillage DRJ, Passariello M, Laffan M, Aw TC, Owen L, Banya W, Trimlett R, Morgan C, Patel BV, Pepper J, Ledot S (2018) Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure. Semin Thromb Hemost 44(3):276–286PubMed Arachchillage DRJ, Passariello M, Laffan M, Aw TC, Owen L, Banya W, Trimlett R, Morgan C, Patel BV, Pepper J, Ledot S (2018) Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure. Semin Thromb Hemost 44(3):276–286PubMed
126.
Zurück zum Zitat Li Z, Li X, Huang Y-Y, Zhou L, Liu R, Wu D, Zhang L, Liu H, Xu X, Zhang Y, Cui J, Wang X, Luo H-B (2020) FEP-based screening prompts drug repositioning against COVID-19. bioRxiv 2020 2020.03.23. 004580 Li Z, Li X, Huang Y-Y, Zhou L, Liu R, Wu D, Zhang L, Liu H, Xu X, Zhang Y, Cui J, Wang X, Luo H-B (2020) FEP-based screening prompts drug repositioning against COVID-19. bioRxiv 2020 2020.03.23. 004580
127.
Zurück zum Zitat Liu X, Li Z, Liu S, Sun J, Chen Z, Jiang M, Zhang Q, Wei Y, Wang X, Huang Y-Y, Shi Y, Xu Y, Xian H, Bai F, Ou C, Xiong B, Lew AM, Cui J, Fang R, Huang H, Zhao J, Hong X, Zhang Y, Zhou F, Luo H-B (2020) Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta PharmSin B. https://doi.org/10.1016/j.apsb.2020.04.008 Liu X, Li Z, Liu S, Sun J, Chen Z, Jiang M, Zhang Q, Wei Y, Wang X, Huang Y-Y, Shi Y, Xu Y, Xian H, Bai F, Ou C, Xiong B, Lew AM, Cui J, Fang R, Huang H, Zhao J, Hong X, Zhang Y, Zhou F, Luo H-B (2020) Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta PharmSin B. https://​doi.​org/​10.​1016/​j.​apsb.​2020.​04.​008
128.
Zurück zum Zitat Jose RJ, Manuel A (2020) COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med S2213–2600(20):30216–30212 Jose RJ, Manuel A (2020) COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med S2213–2600(20):30216–30212
129.
Zurück zum Zitat Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan TP (2020) Short-term dexamethasone in Sars-CoV-2 Patients. R I Med J (2013) 103(6):39–43 Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan TP (2020) Short-term dexamethasone in Sars-CoV-2 Patients. R I Med J (2013) 103(6):39–43
131.
Metadaten
Titel
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
verfasst von
Alessandro Allegra
Vanessa Innao
Andrea Gaetano Allegra
Caterina Musolino
Publikationsdatum
15.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 9/2020
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-020-04182-4

Weitere Artikel der Ausgabe 9/2020

Annals of Hematology 9/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.